Pfizer says they are working on Omicron specific vaccine if needed.
Pfizer and BioNTech says its preliminary lab tests suggest a third dose of its vaccine is providing strong protection agains the Omicron variant.
With health officials urging people to get a third dose, Pfizer has released a study on whether booster shots of its COVID-19 vaccine may make an important difference.
The company says a booster dose may offer significant protection against the new Omicron variant even though the initial two doses appear significantly less effective.
Pfizer-BioNTech says its already working on creating an Omicron-specific vaccine and could have it ready for March of 2022 if needed.
Region Updated on Measles Outbreak
St. Catharines Draws X Through X
Police Looking for Laundry Thief
Toronto Man Charged with Trafficking
Niagara Falls Man Charged with Trafficking
Painting Honours Kristen French
Keeping Douglas Memorial Public is Goal: Mayor
Tourism Awards Received in Niagara